Download presentation
Presentation is loading. Please wait.
Published byAnne Kähkönen Modified over 5 years ago
1
Prevalence of prescribing of different anti-diabetic medications among all patients with type 2 diabetes on treatment. *Other=Sum of prevalence of Acarbose, GLP-1 analogues, Meglitinides and SGLT-2 inhibitors. **For detailed values of point estimates and CIs, please consult online supplementary appendix 3. Prevalence of prescribing of different anti-diabetic medications among all patients with type 2 diabetes on treatment. *Other=Sum of prevalence of Acarbose, GLP-1 analogues, Meglitinides and SGLT-2 inhibitors. **For detailed values of point estimates and CIs, please consult online supplementary appendix 3. Manuj Sharma et al. BMJ Open 2016;6:e010210 ©2016 by British Medical Journal Publishing Group
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.